Abstract 13600: Evaluation of the Risk of All-Cause Mortality With and Without Antithrombotic Therapy in Patients with Newly Diagnosed Atrial Fibrillation and Low-to-Moderate Stroke Risk
Background: Evidence regarding the impact of antithrombotic therapy on mortality in atrial fibrillation (AF) patients with low-to-moderate stroke risk remains uncertain. We evaluated the risk of all-cause mortality in low-to-moderate stroke risk AF patient categories and examine the association of event rates with a...